NLSHP Updates in the Management of C. Difficile Infections

NLSHP Updates in the Management of C. Difficile Infections
0179-9999-18-001-L01-P/T
TYPE OF ACTIVITY/WHO SHOULD ATTEND:
This knowledge-based activity is of importance to all pharmacists.

LEARNING OBJECTIVES:
At the conclusion of this activity, pharmacists should be able to:
1. Identify risk factors for the development of Clostridium difficile infections (CDI).
2. Recognize laboratory findings used in the diagnosis and management of CDI.
3. Select effective treatment regimens for CDI based on current literature and guidelines.
 
At the conclusion of this activity, technicians should be able to:
1. Identify risk factors for the development of Clostridium difficile infections (CDI).
2. Recognize medications used in the treatment of CDI.
 
FACULTY: 
Ashley Selby, PharmD, BCPS, BCCCP, University Health Shreveport 

FEES:  There are no fees for attendance at the meeting for LSHP members.  For non-LSHP members, there will be a $10 fee for continuing education credit.  

RSVP: Kathryn Reynolds by e-mail at kastle3@gmail.com or 727-410-1873

SPONSORED BY:  This activity is sponsored by the North Louisiana Society of Health-System Pharmacists.
When
3/29/2018 7:00 PM
Where
ULM School of Pharmacy Shreveport